Joel Koenig
Pediatrics · St. Louis, MONPI 1578676235
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 445 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Neos Therapeutics, LP at 29.4% of the total. 2025 is the largest year on record at $1,217, 2.2 times the $551 reported in 2019. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 445 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neos Therapeutics, LP$2K
- Corium, LLC$1K
- Supernus Pharmaceuticals, Inc.$676
- Ironshore Pharmaceuticals Inc.$603
- GSK$405
- Tris Pharma Inc$370
- plus $1K from 20 others
What the payments were for
- Food & beverage$6,39699%
- Education$481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neos Therapeutics, LP | 136 | $1,895 |
| Corium, LLC | 85 | $1,219 |
| Supernus Pharmaceuticals, Inc. | 42 | $676 |
| Ironshore Pharmaceuticals Inc. | 45 | $603 |
| GSK | 18 | $405 |
| Tris Pharma Inc | 24 | $370 |
| Collegium Pharmaceutical, Inc. | 30 | $211 |
| Kaleo, Inc. | 11 | $165 |
| Pfizer | 7 | $136 |
| Sanofi Pasteur Inc. | 6 | $96 |
| Genentech USA, Inc. | 5 | $84 |
| Aytu Biopharma, Inc. | 4 | $78 |
| Cranial Technologies, Inc | 5 | $73 |
| Arbor Pharmaceuticals, Inc. | 5 | $62 |
| Noven Therapeutics, LLC | 3 | $49 |
| Vertical Pharmaceuticals, LLC | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Alk-abello, Inc | 2 | $42 |
| Rhodes Pharmaceuticals L.p. | 2 | $39 |
| Novartis | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Seqirus USA Inc | 1 | $20 |
| Merck | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Tempus AI, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEXSERO$125
How this compares
$6,444 in reported general payments places this provider in the 95th percentile of 1,306 pediatrics providers in Missouri.
Other pediatrics in St. Louis
- Lauren HayesSt. Louis$4K
- Mary KopskySt. Louis$3K
- Molly FiggemeierSaint Louis$74K
- Terri LuetjenKansas City$57K
- Alexander FaySaint Louis$53K
- Kevin MurphyFlorissant$52K
- Sharon HumistonKansas City$41K
- Nikita RajeKansas City$23K
- Natasha BurgertKansas City$20K
- John GalganiHazelwood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.